Connect with us

Health

Report: FDA official fast-tracked colleague's SSRI petition after presenting his research as her own

Published

on




The woman now running the FDA’s powerful drug center presented a colleague’s research as her own, agency staffers say, then moved to hire that colleague and press for faster review of his petition seeking a new warning label on antidepressants used by millions of pregnant women.



Source link

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *